General Archive
-
Gates Foundation: a $5 million partnership to make monoclonal antibodies more accessible
Gates Foundation: a $5 million partnership to make monoclonal antibodies more accessible We have partnered with the Gates Foundation and…
-
News releasesLifeArc and the Gates Foundation launches groundbreaking new projects to lower the cost of monoclonal antibody production
We have partnered with the Gates Foundation to fund seven new projects aimed at reducing the costs of manufacturing monoclonal…
-
BlogsWe must confront this silent pandemic as a global collective
Antimicrobial resistance (AMR) is often called the silent pandemic but for those of us working in this space, we are…
-
News releasesPACE announces £6 million funding for antibacterial treatment innovations to fill critical gap in R&D pipeline
PACE (Pathways to Antimicrobial Clinical Efficacy) launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections…
-
ASPIRE: The Antibiotic Stewardship Programme through Innovation, Research, and Education
-
News releasesLifeArc joins transatlantic collaboration to develop a treatment for Crimean-Congo Hemorrhagic Fever
A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to…
-
USAMRIID: A transatlantic collaboration to develop a treatment for Crimean-Congo hemorrhagic fever
USAMRIID: A transatlantic collaboration to develop a treatment for Crimean-Congo hemorrhagic fever We have joined forces with the U.S. Army…
-
TIME study: TB DIagnosis and Monitoring Evaluation
-
Accelerating dengue solutions: Boosting early-stage research efforts in India and Australia
Accelerating dengue solutions: Boosting early-stage research efforts in India and Australia We are providing funding, expertise and advice to 3…
-
DOSA2: A collaborative project to combat antimicrobial resistance
DOSA2: A collaborative project to combat antimicrobial resistance A project to advance diagnostics for urinary tract infections (UTIs) to help…
-
CTAR: A centre for translational antimicrobial resistance research
CTAR: A centre for translational antimicrobial resistance research We have committed £5 million to co-establish the new Centre for Translational…
-
The Newborn Survival Prize: A partnership to combat neonatal sepsis
The Newborn Survival Prize: A partnership to combat neonatal sepsis A global prize with Challenge Works to reduce neonatal mortality…